Streamlining analysis of ion channel in vitro assays data to support c

by Pill Pals Customer Service | Aug 4, 2025 | News

SummaryCDER researchers are developing an approach that enables sharing and analyzing large volumes of cardiac electrophysiology in vitro data and streamlines the analysis and interpretation of these nonclinical data to support clinical cardiac safety decision...

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (Containing Benzyl Alcohol), Due To The Potential Presence of Visible Particulates

by Pill Pals Customer Service | Aug 1, 2025 | News

Summary Company Announcement Date: August 22, 2022 FDA Publish Date: August 22, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential presence of visible particulate Company Name: Hospira, Inc., a Pfizer Company Brand Name: Product...

Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension and Magnesium Hydroxide /Aluminum Hydroxide /Simethicone Oral Suspension Due to Microbial Contamination

by Pill Pals Customer Service | Aug 1, 2025 | News

Summary Company Announcement Date: June 08, 2022 FDA Publish Date: June 08, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to microbial contamination Company Name: Plastikon Healthcare, LLC Brand Name: Product Description: Product...

Drug Compliance Programs

by Pill Pals Customer Service | Aug 1, 2025 | News

FDA compliance programs provide guidance and instructions to FDA staff for obtaining information to help fulfill agency plans in the specified program area. These compliance programs neither create or confer any rights for, or on, any person and do not operate to bind...

Physicochemical and Structural (Q3) Characterization of Topical Drug

by Pill Pals Customer Service | Jul 31, 2025 | News

Docket Number: FDA-2022-D-1864 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research, Office of Regulatory Policy This guidance is intended to assist applicants who are submitting abbreviated new drug applications (ANDAs) for liquid-based and/or...

« Older Entries

Next Entries »